View Article

Abstract

A common neurological condition called migraine is typified by recurrent, throbbing headaches that are frequently accompanied by other symptoms like nausea, light sensitivity, and aura. An extensive review of migraine, including its epidemiology, pathophysiology, clinical manifestation, triggers, and risk factors, is given in this work. There is a discussion of the diagnostic standards and the many acute and preventive treatment choices. The effects of migraines on one's physical and psychological well-being are examined, highlighting the necessity of managing the condition holistically. The article also explores recent findings and novel treatments, emphasizing how migraine treatment is developing. This succinct summary seeks to raise knowledge and comprehension of migraine, encouraging better management techniques and better results for those who suffer from this crippling ailment..

Keywords

Migraine, Neurological disorder, Headache, Treatment options, Quality of life

Reference

  1. Gupta J, Gaurkar S S (August 24, 2022) Migraine: An Underestimated Neurological Condition Affecting Billions. Cureus 14(8): e28347. doi:10.7759/cureus.28347
  2. Weatherall MW. The diagnosis and treatment of chronic migraine. Therapeutic Advances in Chronic Disease. 2015;6(3):115-123. doi:10.1177/2040622315579627
  3. Stovner, L.J., Hagen, K., Linde, M. et al. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23, 34 (2022). https://doi.org/10.1186/s10194-022-01402-2
  4. Johra Khan, Et. al,Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine,Biomedicine&Pharmacotherapy,Volume 139,2021,111557,ISSN 0753-3322, https://doi.org/10.1016/j.biopha.2021.111557.
  5. PescadorRuschel MA, De Jesus O. Migraine Headache. [Updated 2023 Aug 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560787/
  6. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017 Apr;97(2):553-622. doi: 10.1152/physrev.00034.2015. PMID: 28179394; PMCID: PMC5539409.
  7. Aggarwal M, Puri V, Puri S. Serotonin and CGRP in migraine. Ann Neurosci. 2012 Apr;19(2):88-94. doi: 10.5214/ans.0972.7531.12190210. PMID: 25205974; PMCID: PMC4117050.
  8. Simonetta I, Riolo R, Todaro F, Tuttolomondo A. New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach. International Journal of Molecular Sciences. 2022; 23(6):3018. https://doi.org/10.3390/ijms23063018
  9. Spekker E, Nagy-Grócz G, Vécsei L. Ion Channel Disturbances in Migraine Headache: Exploring the Potential Role of the Kynurenine System in the Context of the Trigeminovascular System. International Journal of Molecular Sciences. 2023; 24(23):16574. https://doi.org/10.3390/ijms242316574
  10. Bron C, Sutherland HG, Griffiths LR. Exploring the Hereditary Nature of Migraine. Neuropsychiatr Dis Treat. 2021 Apr 22;17:1183-1194. doi: 10.2147/NDT.S282562. PMID: 33911866; PMCID: PMC8075356.
  11. Fila M, Paw?owska E, Blasiak J. Mitochondria in migraine pathophysiology - does epigenetics play a role? Arch Med Sci. 2019 Jul;15(4):944-956. doi: 10.5114/aoms.2019.86061. Epub 2019 Jun 20. PMID: 31360189; PMCID: PMC6657237.
  12. Ple? H, Florian I-A, Timis T-L, Covache-Busuioc R-A, Glavan L-A, Dumitrascu D-I, Popa AA, Bordeianu A, Ciurea AV. Migraine: Advances in the Pathogenesis and Treatment. Neurology International. 2023; 15(3):1052-1105. https://doi.org/10.3390/neurolint15030067
  13. Soumitra Ghosh and Warren G. Tourtellotte, The Complex Clinical and Genetic Landscape of Hereditary Peripheral Neuropathy, Annual Review of Pathology: Mechanisms of Disease 2021 16:1, 487-509, https://doi.org/10.1146/annurev-pathol-030320-100822
  14. Ahmed F. Headache disorders: differentiating and managing the common subtypes. Br J Pain. 2012 Aug;6(3):124-32. doi: 10.1177/2049463712459691. PMID: 26516483; PMCID: PMC4590146.
  15. Ravishankar K. The art of history-taking in a headache patient. Ann Indian Acad Neurol. 2012 Aug;15(Suppl 1):S7-S14. doi: 10.4103/0972-2327.99989. PMID: 23024567; PMCID: PMC3444228.
  16. Weatherall MW. The diagnosis and treatment of chronic migraine. TherAdv Chronic Dis. 2015 May;6(3):115-23. doi: 10.1177/2040622315579627. PMID: 25954496; PMCID: PMC4416971.
  17. Eigenbrodt AK, et. al, Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021 Aug;17(8):501-514. doi: 10.1038/s41582-021-00509-5. Epub 2021 Jun 18. PMID: 34145431; PMCID: PMC8321897.
  18. Bahra A. Primary Headache Disorders: Focus on Migraine. Rev Pain. 2011 Dec;5(4):2-11. doi: 10.1177/204946371100500402. PMID: 26525886; PMCID: PMC4590049.
  19. Amiri P, et al Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022 Feb 23;12:800605. doi: 10.3389/fneur.2021.800605. PMID: 35281991; PMCID: PMC8904749.
  20. Bron C, et al Exploring the Hereditary Nature of Migraine. Neuropsychiatr Dis Treat. 2021 Apr 22;17:1183-1194. doi: 10.2147/NDT.S282562. PMID: 33911866; PMCID: PMC8075356.
  21. Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009 May;84(5):422-35. doi: 10.1016/S0025-6196(11)60561-2. PMID: 19411439; PMCID: PMC2676125.
  22. Burton WN, Landy SH, Downs KE, Runken MC. The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc. 2009 May;84(5):436-45. doi: 10.1016/S0025-6196(11)60562-4. PMID: 19411440; PMCID: PMC2676126.
  23. Al-Hassany L, Haas J, Piccininni M, Kurth T, Maassen Van Den Brink A, Rohmann JL. Giving Researchers a Headache - Sex and Gender Differences in Migraine. Front Neurol. 2020;11:549038. Published 2020 Oct 22. doi:10.3389/fneur.2020.549038
  24. Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurol Sci. 2020;41(Suppl 2):429-436. doi:10.1007/s10072-020-04643-8
  25. Aggarwal M, Puri V, Puri S. Serotonin and CGRP in migraine. Ann Neurosci. 2012;19(2):88-94. doi:10.5214/ans.0972.7531.12190210
  26. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97(2):553-622. doi:10.1152/physrev.00034.2015
  27. Panconesi, A. Serotonin and migraine: a reconsideration of the central theory. J Headache Pain 9, 267–276 (2008). https://doi.org/10.1007/s10194-008-0058-2
  28. Charles A, Brennan KC. The neurobiology of migraine. Handb Clin Neurol. 2010;97:99-108. doi:10.1016/S0072-9752(10)97007-3
  29. Mason BN and Russo AF (2018) Vascular Contributions to Migraine: Time to Revisit? Front. Cell. Neurosci. 12:233. doi: 10.3389/fncel.2018.00233
  30. Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31(1):17-35. doi:10.1038/jcbfm.2010.191
  31. Cui Y, Kataoka Y, Watanabe Y. Role of cortical spreading depression in the pathophysiology of migraine. Neurosci Bull. 2014;30(5):812-822. doi:10.1007/s12264-014-1471-y
  32. Harriott, A.M., Takizawa, T., Chung, D.Y. et al. Spreading depression as a preclinical model of migraine. J Headache Pain 20, 45 (2019). https://doi.org/10.1186/s10194-019-1001-4
  33. Costa, C., Tozzi, A., Rainero, I. et al. Cortical spreading depression as a target for anti-migraine agents. J Headache Pain 14, 62 (2013). https://doi.org/10.1186/1129-2377-14-62
  34. Rogawski MA. Common Pathophysiologic Mechanisms in Migraine and Epilepsy. Arch Neurol. 2008;65(6):709–714. doi:10.1001/archneur.65.6.709
  35. Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol. 2010;9(3):309-317. doi:10.1016/S1474-4422(09)70358-8
  36. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-366. doi:10.1146/annurev.med.60.042307.110802
  37. Malhotra R. Understanding migraine: Potential role of neurogenic inflammation. Ann Indian Acad Neurol. 2016;19(2):175-182. doi:10.4103/0972-2327.182302
  38. Shibata Y. Migraine Pathophysiology Revisited: Proposal of a New Molecular Theory of Migraine Pathophysiology and Headache Diagnostic Criteria. International Journal of Molecular Sciences. 2022; 23(21):13002. https://doi.org/10.3390/ijms232113002
  39. Ple? H, Florian I-A, Timis T-L, Covache-Busuioc R-A, Glavan L-A, Dumitrascu D-I, Popa AA, Bordeianu A, Ciurea AV. Migraine: Advances in the Pathogenesis and Treatment. Neurology International. 2023; 15(3):1052-1105. https://doi.org/10.3390/neurolint15030067
  40. Papetti L, Moavero R, Ferilli MAN, et al. Truths and Myths in Pediatric Migraine and Nutrition. Nutrients. 2021;13(8):2714. Published 2021 Aug 6. doi:10.3390/nu13082714
  41. Gammone MA, Vicentini A, Riccioni G, De Girolamo M, D’Aulerio A, D’Orazio N. Food-Related Atrial Fibrillation? The Potential Role of Biogenic Amines in “Nutri-Arrhythmias” Genesis. Reports. 2019; 2(1):1. https://doi.org/10.3390/reports2010001
  42. Finocchi, Cinzia & Sivori, Giorgia. (2012). Food as trigger and aggravating factor of migraine. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 33 Suppl 1. S77-80. 10.1007/s10072-012-1046-5.
  43. Maleki N, Becerra L, Borsook D. Migraine: maladaptive brain responses to stress. Headache. 2012;52 Suppl 2(Suppl 2):102-106. doi:10.1111/j.1526-4610.2012.02241.x
  44. Kang JH, Chen SC. Effects of an irregular bedtime schedule on sleep quality, daytime sleepiness, and fatigue among university students in Taiwan. BMC Public Health. 2009;9:248. Published 2009 Jul 19. doi:10.1186/1471-2458-9-248
  45. Institute of Medicine (US) Committee on Sleep Medicine and Research; Colten HR, Altevogt BM, editors. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington (DC): National Academies Press (US); 2006. 3, Extent and Health Consequences of Chronic Sleep Loss and Sleep Disorders. Available from: https://www.ncbi.nlm.nih.gov/books/NBK19961/
  46. Pergolizzi, J.V., Magnusson, P., LeQuang, J.A. et al. Exploring the Connection Between Sleep and Cluster Headache: A Narrative Review. Pain Ther 9, 359–371 (2020). https://doi.org/10.1007/s40122-020-00172-6
  47. Luciana Besedovsky, Tanja Lange, and Monika Haack, The Sleep-Immune Crosstalk in Health and Disease, Physiological Reviews 2019 99:3, 1325-1380
  48. Agbetou M, Adoukonou T. Lifestyle Modifications for Migraine Management. Front Neurol. 2022;13:719467. Published 2022 Mar 18. doi:10.3389/fneur.2022.719467
  49. D'Amico D, Tepper SJ. Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat. 2008;4(6):1155-1167. doi:10.2147/ndt.s3497
  50. Weatherall MW. The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis. 2015;6(3):115-123. doi:10.1177/2040622315579627
  51. Eigenbrodt, A.K., Ashina, H., Khan, S. et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17, 501–514 (2021). https://doi.org/10.1038/s41582-021-00509-5
  52. Ravishankar K. The art of history-taking in a headache patient. Ann Indian Acad Neurol. 2012;15(Suppl 1):S7-S14. doi:10.4103/0972-2327.99989
  53. Ahmed F. Headache disorders: differentiating and managing the common subtypes. Br J Pain. 2012;6(3):124-132. doi:10.1177/2049463712459691
  54. Steiner, T.J., Jensen, R., Katsarava, Z. et al. Aids to management of headache disorders in primary care (2nd edition). J Headache Pain 20, 57 (2019). https://doi.org/10.1186/s10194-018-0899-2
  55. Pardutz A, Schoenen J. NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data. Pharmaceuticals (Basel). 2010;3(6):1966-1987. Published 2010 Jun 17. doi:10.3390/ph3061966
  56. Ong JJY, De Felice M. Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action [published correction appears in Neurotherapeutics. 2018 Jan 8;:]. Neurotherapeutics. 2018;15(2):274-290. doi:10.1007/s13311-017-0592-1
  57. Laura Mayans, Acute Migraine Headache: Treatment Strategies, Am Fam Physician. 2018;97(4):243-251
  58. Kumar A, Kadian R. Migraine Prophylaxis. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507873/
  59. Silberstein, Stephen, "Preventive treatment of migraine" (2006).Department of Neurology, Faculty Papers. Paper 19., https://jdc.jefferson.edu/neurologyfp/19
  60. Silberstein SD. Preventive Migraine Treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973-989. doi:10.1212/CON.0000000000000199
  61. Duncan Smyth, Zelie Britton, Louisa Murdin, Qadeer Arshad, Diego Kaski, Vestibular migraine treatment: a comprehensive practical review, Brain, Volume 145, Issue 11, November 2022, Pages 3741–3754, https://doi.org/10.1093/brain/awac264
  62. Pallapothu M R, Quintana Mariñez M G, Chakkera M, et al. (October 08, 2023) Long-Term Management of Migraine With OnabotulinumtoxinA (Botox) vs Calcitonin Gene-Related Peptide Antibodies (Anti-CGRP). Cureus 15(10): e46696. doi:10.7759/cureus.46696
  63. Diener H-C, Holle-Lee D, Nägel S, et al. Treatment of migraine attacks and prevention of migraine: Guidelines by the German Migraine and Headache Society and the German Society of Neurology. Clinical and Translational Neuroscience. 2019;3(1). doi:10.1177/2514183X18823377
  64. Simonetta I, Riolo R, Todaro F, Tuttolomondo A. New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach. International Journal of Molecular Sciences. 2022; 23(6):3018. https://doi.org/10.3390/ijms23063018
  65. Edvinsson L. Role of CGRP in Migraine. Handb Exp Pharmacol. 2019;255:121-130. doi: 10.1007/164_2018_201. PMID: 30725283.
  66. Haghdoost F, Togha M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Med (Wars). 2022;17(1):1869-1882. Published 2022 Nov 23. doi:10.1515/med-2022-0598
  67. Rashid A, Manghi A. Calcitonin Gene-Related Peptide Receptor. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560648/
  68. Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94(4):1099-1142. doi:10.1152/physrev.00034.2013
  69. Deen, M., Correnti, E., Kamm, K. et al. Blocking CGRP in migraine patients – a review of pros and cons. J Headache Pain 18, 96 (2017). https://doi.org/10.1186/s10194-017-0807-1
  70. Scuteri D, Adornetto A, Rombolà L, Naturale MD, Morrone LA, Bagetta G, Tonin P and Corasaniti MT (2019) New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies. Front. Pharmacol. 10:363. doi: 10.3389/fphar.2019.00363
  71. Garelja, M. L., Walker, C. S., & Hay, D. L. (2022). CGRP receptor antagonists for migraine. Are they also AMY1 receptor antagonists? British Journal of Pharmacology, 179(3), 454–459. https://doi.org/10.1111/bph.15585
  72. Rashid A, Manghi A. Calcitonin Gene-Related Peptide Receptor. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560648/
  73. Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94(4):1099-1142. doi:10.1152/physrev.00034.2013
  74. Deen, M., Correnti, E., Kamm, K. et al. Blocking CGRP in migraine patients – a review of pros and cons. J Headache Pain 18, 96 (2017). https://doi.org/10.1186/s10194-017-0807-1
  75. Scuteri D, Adornetto A, Rombolà L, Naturale MD, Morrone LA, Bagetta G, Tonin P and Corasaniti MT (2019) New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies. Front. Pharmacol. 10:363. doi: 10.3389/fphar.2019.00363
  76. Garelja, M. L., Walker, C. S., & Hay, D. L. (2022). CGRP receptor antagonists for migraine. Are they also AMY1 receptor antagonists? British Journal of Pharmacology, 179(3), 454–459. https://doi.org/10.1111/bph.15585
  77. Miller S, Sinclair AJ, Davies B, et al Neurostimulation in the treatment of primary headaches, Practical Neurology 2016;16:362-375.
  78. Todd J. Schwedt, Bert Vargas, Neurostimulation for Treatment of Migraine and Cluster Headache, Pain Medicine, Volume 16, Issue 9, September 2015, Pages 1827–1834, https://doi.org/10.1111/pme.12792
  79. Coppola, G., Magis, D., Casillo, F. et al. Neuromodulation for Chronic Daily Headache. Curr Pain Headache Rep 26, 267–278 (2022). https://doi.org/10.1007/s11916-022-01025-x
  80. Antonaci F, Ghiotto N, Wu S, Pucci E, Costa A. Recent advances in migraine therapy. Springerplus. 2016;5:637. Published 2016 May 17. doi:10.1186/s40064-016-2211-8
  81. Al-Quliti KW, Assaedi ES. New advances in prevention of migraine. Review of current practice and recent advances. Neurosciences (Riyadh). 2016;21(3):207-214. doi:10.17712/nsj.2016.3.20150506

Photo
Dipali V. Mane
Corresponding author

Assistant Professor, Shriram Shikshan Snatha’s College of Pharmacy, Paniv-413113

Photo
Rashmi R. Balkate
Co-author

Assistant Professor, Shriram Shikshan Snatha’s College of Pharmacy, Paniv-413113

Photo
Vanita H. Shinde
Co-author

Assistant Professor, Shriram Shikshan Snatha’s College of Pharmacy, Paniv-413113

Dipali V. Mane, Rashmi R. Balkate , Vanita H. Shinde, New Therapeutic approaches for Migraine: A brief overview, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 1, 541-553. https://doi.org/10.5281/zenodo.10557272

More related articles
Screening of phytochemicals and Antifungal evaluat...
Shivani Sharma, Dev Prashad Dahiya, Akhil Sharma, Chinu kumari, ...
A Comparative Study of Ketorolac, Paracetamol and ...
Syed Jaffer, Shaista Sumayya, Meraj fatima, Safa mehboobunnisa si...
An Overview of regulatory affairs in Pharmaceutica...
Vaibhav Bhausaheb mote , S.S.Devkar, R.M.Kawade, ...
View more
Mirroring The Mystery By Mapping Out The Molybdenum From Vigna Unguiculata ...
K.MOUNIKA, DR.K.B.ILANGO, M.S.AJITH, S.BABU, T.VINOTHINI, D.KALPANA, B.NISHANTH KANNAN, R.RAMYA, R.S...
Review On Nanosponges; A Nanotechnology Drug Delivery System...
Hasna EK, Junise V, Farhana MK, Shilpa KD, ...
Insights into immune thrombocytopenic purpura: a rare hematological disorder ...
Dhanya Dharman , Ahalya U, Praveena R Prasad, Shaiju S Dharan, ...
View more
Download PDF
Related Articles
Demographic Factors Based On Predicting Mental Health Of Caronavirus Victims...
Dr. Vijayalakshmi Kakulapati, Shaik Subhani, Gowripriya Kukunuri, Pallavi KSL Lakkoju, ...
Studies On Various Classification Of Antihypertensive Drugs ...
Hari P. Sonwani, Rashi Bandey, Aafatb Khan, Anjalee, Pragati Kannaujiya, Anupa Bhagat , Muskan Mi...
Telemedicine in health care system:A review ...
Shubham B. Tarle , Akash A. pawar , Sapana K. Sonavane , Manisha P. Padme , Ashwini Dokhale, ...
Evaluation of Phytochemicals in crude extracts derived from the Aerial parts of ...
Arnab Roy, Sajid Ansari, Subham Kumar Lohani , Ayush Kumar, Makhmur Hayat, ...
Screening of phytochemicals and Antifungal evaluation of crude extract of pterid...
Shivani Sharma, Dev Prashad Dahiya, Akhil Sharma, Chinu kumari, ...
More related articles
Screening of phytochemicals and Antifungal evaluation of crude extract of pterid...
Shivani Sharma, Dev Prashad Dahiya, Akhil Sharma, Chinu kumari, ...
A Comparative Study of Ketorolac, Paracetamol and Tramadol for Post Operative Pa...
Syed Jaffer, Shaista Sumayya, Meraj fatima, Safa mehboobunnisa siddiqi, Ruqshan Nazneen, ...
An Overview of regulatory affairs in Pharmaceutical science ...
Vaibhav Bhausaheb mote , S.S.Devkar, R.M.Kawade, ...
View more
Screening of phytochemicals and Antifungal evaluation of crude extract of pterid...
Shivani Sharma, Dev Prashad Dahiya, Akhil Sharma, Chinu kumari, ...
A Comparative Study of Ketorolac, Paracetamol and Tramadol for Post Operative Pa...
Syed Jaffer, Shaista Sumayya, Meraj fatima, Safa mehboobunnisa siddiqi, Ruqshan Nazneen, ...
An Overview of regulatory affairs in Pharmaceutical science ...
Vaibhav Bhausaheb mote , S.S.Devkar, R.M.Kawade, ...
View more

Copyright © 2024 IJPS. All rights reserved